Fox Business - The Power to Prosper
Search Site


Related Topics

Novartis CEO Reshapes Firm For 'Brutal' New World

Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new era in healthcare spending.At least one of the three sub-scale units - animal health, vaccines and over-the-counter medicines - is not expected to make the cut, he told Reuters in the clearest indication yet of how the review is progressing."I really wish we could make all three of those businesses global scale, but I think it's unlikely," Jimenez said.At first blush, Jimenez's vision of a healthcare market that could double in a decade as populations get older and sicker seems like good news. But there is a dark side because budget constraints will make it ever harder to get treatments paid for."It's going to be brutal in terms of getting reimbursement," he said, adding that sub-scale businesses which are not leaders in their fields would be left trailing.While the three smaller divisions make up only 10.5 percent of Novar...

Read More

  1. Novartis: U.S. Probing Export of Alcon Products to Iran, Other Trade-Sanction Countries

    U.S. authorities are investigating the export of products made by Novartis AG's (NVS) Alcon eye-care unit to various countries subject to U.S. trade sanctions, inclu...

  2. Analyzing Mitt Romney’s Position on Abortion

    Planned Parenthood President Cecile Richards talks with Alan about Mitt Romney’s pro-life views.

  3. Novartis Drug Does Well in Trial for Age-Related Eye Disease

    An experimental drug that would eliminate the need for onerous and sometimes risky eye surgery in elderly patients showed promising results in two studies to be publ...

  4. Nestle to Buy Pfizer's Infant Nutrition Unit for $11.9B

    Nestle snatched Pfizer's (NYSE:PFE) infant nutrition business on Monday for nearly $12 billion, making the Swiss food group the largest player in the key Asia-Pacifi...

  5. New in theaters: 3/30

    Check out the movies opening this weekend

  6. UK Regulator Changes Stance On Novartis's Gilenya

    LONDON -- Novartis AG's (NVS) multiple sclerosis pill Gilenya has been recommended for use on the U.K.'s publicly funded National Health Service, a welcome decision ...

  7. Novartis Gets Rights To Sell New Eye Drug Outside US

    Novartis (NVS) said Friday it acquired the rights to an experimental eye treatment from ThromboGenics (THR.BT) of Belgium to sell it outside the U.S., in a deal that...

  8. Nestle Ready For Tough 2012 As Earnings Drop

    VEVEY, Switzerland -( Dow Jones )- Nestle SA (NESN.VX) Thursday maintained its growth targets despite expectations of a tough year ahead as it reported a drop in net...

  9. Nestle Expects Tough 2012 As Earnings Drop

    VEVEY, Switzerland -( Dow Jones )- Nestle SA (NESN.VX) Thursday maintained its growth targets despite expectations of a tough year ahead as it reported a drop in net...

  10. M.I.A. flips bird, causes uproar

    Madonna's halftime show at Super Bowl overshadowed by guest-performer's lewd gesture

  11. Novartis Says Profitability To Decline In 2012

    Switzerland's Novartis AG (NVS) Wednesday said its profitability will decline this year due to competition from generic rivals, continued drug price cuts and the nee...

  12. Novartis Cautious On Outlook As Profit Plunges

    Switzerland's Novartis AG (NVS) Wednesday issued a cautious earnings outlook for 2012 as it reported a 46% drop in fourth-quarter net profit, hit by restructuring co...

  1. Entrepreneur sells promise of future investment to pay off debt

    Nailed Kit CEO Rachel Honeth Kim raised $100K from investors to pay off debt and launch a startup company.

  2. Novartis CEO: Universal health coverage in U.S. is a good objective

    Novartis CEO Joe Jimenez on being one of the Chairs of the World Economic Forum, the drugs in the company’s pipeline and ObamaCare.

  3. Novartis chairman floats idea of business review to appease investors

    Less than two weeks into the job, Novartis AG's new chairman is seeking to appease investors by suggesting the Swiss drugmaker will review some of its underperformin...

  4. Jaden Smith emancipation rumors cause drama

    All about getting legally emancipated

  5. Novartis Gets EU Approval For Eye-Care Drug Jetrea

    Novartis AG (NOVN.VX) Monday said its eye-care division Alcon has received European approval for Jetrea, a drug which treats a condition which can lead to damaged vi...

  6. Coming up on Friday, Feb. 8 edition of ‘Special Report’

    Chris Wallace gives you a sneak peek of the next show

  7. Novartis U.S. Unit Subpoenaed in Marketing Probe

    Swiss drug giant Novartis AG (NVS, NOVN.VX) said its U.S. unit has been subpoenaed as part of a federal investigation into the company's marketing of blood pressure ...

‹ Prev123Next ›
Freebase CC-BY
Source: Alcon on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL